InsuLife AS is a Norwegian biotechnology company that specializes in the development of innovative treatment methods for diabetes. The company has developed Levellor™, a spray-based insulin solution that eliminates the need for needles. This product aims to give diabetes patients greater freedom and improved quality of life by offering a more user-friendly and comfortable administration method.
As pioneers in diabetes treatment, InsuLife AS focuses on revolutionizing the way insulin is administered. The company has ambitions to reach a global market and actively participates in seminars to share updates and information about its progress. Through its work, InsuLife AS seeks to contribute to a better everyday life for people with diabetes.